An Interdisciplinary Curriculum to Optimize Team-Based Management of Amyloid-Related Imaging Abnormalities in Alzheimer’s Disease
Join the New Age of Alzheimer's Disease Care: A Focus on Amyloid Related Imaging Abnormalities (ARIA)
The introduction of disease modifying amyloid targeting therapies for Alzheimer’s disease is creating a paradigm shift in the treatment of patients with this condition. But the potential for ARIA prompts several unique considerations over the course of therapy. This curriculum is designed to outline critical roles and best practices in ARIA identification and management across disciplines to prepare you to navigate real-world clinical scenarios.
Watch the Video: Welcome to the ARIA Toolkit
Chuck Vega, MD
Initiative Chairperson
CLOSE
Educational Programs
Resource Center
Discover a curated collection of foundational, practical, and real-world educational resources at your fingertips. Click on a link to get started.
Steering Committee
From academia to private practice, we are joined together to change the outcomes of our patients. Get to know the renowned expert faculty that are the driving force behind The ARIA Toolkit.
James R. Bateman, MD, MPH
Assistant Professor of Neurology, Psychiatry and Behavioral Medicine, and Geriatrics
Wake Forest University School of Medicine
Winston-Salem, NC
B. Joy Snider, MD, PhD
Professor of Neurology
Knight Alzheimer Disease Research Center at Washington University School of Medicine
Saint Louis, MO
Danya Khoujah, MBBS
Attending Physician, Department of Emergency Medicine Tampa
AdventHealth, Tampa, FL Volunteer Adjunct Assistant Professor,
Department of Emergency Medicine
University of Maryland School of Medicine, Baltimore, MD
Chuck Vega, MD
Health Sciences Clinical Professor
UC Irvine Department of Family Medicine
Director, UCI Program in Medical Education for the Latino Community
Assistant Dean for Culture and Community Education
UC Irvine School of Medicine
More About This Initiative
An interdisciplinary multi-component curriculum
The age of disease modifying therapy has arrived with the introduction of amyloid targeting therapies. However, with this novel therapeutic class comes a novel adverse event. From foundational information through active case-based simulation, this initiative’s components provide options for all skill levels and allow you to build and apply your ARIA knowledge with each sequential module.